title: Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with adalimumab.
authors.affiliation: Department of Rheumatology, Burton Hospital NHS Foundation Trust, Burton-on-Trent, United Kingdom.
authors.forename: Subha
authors.initials: S
authors.lastname: Arthanari
authors.forename: Hume
authors.initials: H
authors.lastname: Ahmad
authors.forename: Mohamed
authors.initials: M
authors.lastname: Nisar
mesh_terms: D015746:Abdominal Pain / Q000139:chemically induced; D000068879:Adalimumab; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004438:Ecchymosis / Q000139:chemically induced; D005076:Exanthema / Q000139:chemically induced; D017809:Fatal Outcome; D005260:Female; D006406:Hematoma / Q000139:chemically induced; D006467:Hemophilia A / Q000139:chemically induced* / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011658:Pulmonary Fibrosis / Q000150:complications; D014057:Tomography, X-Ray Computed
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D000068879:Adalimumab